Claudia Giesecke-Thiel

Max Planck Institute of Molecular Cell Biology and Genetics

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Marcel Mueller

Group leader/ Prof. Dr. rer. nat.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Sigmar Stricker

Professor

GERMANY

View details

Julian Braun

Charité - Universitätsmedizin Berlin

GERMANY

View details

Lucie Loyal

Charité - Universitätsmedizin Berlin

GERMANY

View details

Andreas Thiel

Professor

GERMANY

View details

Toralf Roch

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Chotima Böttcher

Charité - Universitätsmedizin Berlin

GERMANY

View details

Kathrin de la Rosa

Group Leader/ Professor

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claudia Giesecke-Thiel

Research Interests

Explore related searches

Contact this professor

Articles (10)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.

A local subset of mesenchymal cells expressing the transcription factor Osr1 orchestrates lymph node initiation.

Odd skipped-related 1 controls the pro-regenerative response of fibro-adipogenic progenitors

Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly.

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Multi-angle pulse shape detection of scattered light in flow cytometry for label-free cell cycle classification

Dnmt1 has de novo activity targeted to transposable elements.

Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment

Collaborators (8)

Marcel Mueller

Sigmar Stricker

Julian Braun

Lucie Loyal

Andreas Thiel

Toralf Roch

Chotima Böttcher

Kathrin de la Rosa

Make your next move.